Professional role
Chair of the American Psychiatric Association Neuromodulation Caucus[1]
AZ
He has received multiple awards for clinical, academic, and research excellence
His work emphasizes access, quality, and patient-centered innovation
maintains international collaborations with universities in Egypt
clinical research in adolescent depression · continues outcomes-focused research that advances protocol optimization and implementation in academic health systems · evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders · transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies
Reviewed sources document clinical research in adolescent depression, continues outcomes-focused research that advances protocol optimization and implementation in academic health systems, evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, and transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. Explore attributed publications and research affiliations.
Explore researchclinical research in adolescent depression[1]
continues outcomes-focused research that advances protocol optimization and implementation in academic health systems[1]
evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders[1]
transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies[1]
Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.
13 source claims · Reviewed Sep 9, 2026
Biographical context: He has received multiple awards for clinical, academic, and research excellence
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Biographical context: His work emphasizes access, quality, and patient-centered innovation
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Biographical context: maintains international collaborations with universities in Egypt
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Degree: MD
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Identity: Ahmed Z. Elmaadawi, MD
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Professional role: Chair of the American Psychiatric Association Neuromodulation Caucus
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Professional role: Clinical Associate Professor of Psychiatry
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Professional role: Director of Interventional Psychiatry Service
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Official profile: Official profile
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Research interests: clinical research in adolescent depression
Dr. Elmaadawi has led and contributed to clinical research in adolescent depression
Research interests: continues outcomes-focused research that advances protocol optimization and implementation in academic health systems
Ahmed Z. Elmaadawi, MD, is Clinical Associate Professor of Psychiatry and Director of Interventional Psychiatry Service at the University of Arizona College of Medicine–Phoenix and Banner–University Medical Center Phoenix. His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders, with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies. His work emphasizes access, quality, and patient-centered innovation. Dr. Elmaadawi has led and contributed to clinical research in adolescent depression, including adolescent TMS trials, and continues outcomes-focused research that advances protocol optimization and implementation in academic health systems. He has received multiple awards for clinical, academic, and research excellence, maintains international collaborations with universities in Egypt, and serves as Chair of the American Psychiatric Association Neuromodulation Caucus.
Research interests: evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders
His work centers on evidence-based interventional psychiatry and neuromodulation for treatment-resistant mood disorders
Research interests: transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies
with a focus on transcranial magnetic stimulation (TMS) and ketamine/esketamine therapies